MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1
- 1 March 1999
- journal article
- Published by Springer Nature in Leukemia
- Vol. 13 (3) , 348-357
- https://doi.org/10.1038/sj.leu.2401360
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 0 references indexed in Scilit: